Department of Clinical Nutrition, School of Nutrition and Food Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Nutrition, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.
World J Pediatr. 2023 Apr;19(4):356-365. doi: 10.1007/s12519-022-00664-9. Epub 2022 Dec 9.
Recently, beneficial effects of probiotics and/or prebiotics on cardio-metabolic risk factors in adults have been shown. However, existing evidence has not been fully established for pediatric age groups. This study aimed to assess the effect of synbiotic on anthropometric indices and body composition in overweight or obese children and adolescents.
This randomized double-blind, placebo-controlled trial was conducted among 60 participants aged 8-18 years with a body mass index (BMI) equal to or higher than the 85th percentile. Participants were randomly divided into two groups that received either a synbiotic capsule containing 6 × 10 colony forming units (CFU) Lactobacillus coagulans SC-208, 6 × 10 CFU Lactobacillus indicus HU36 and fructooligosaccharide as a prebiotic (n = 30) or a placebo (n = 30) twice a day for eight weeks. Anthropometric indices and body composition were measured at baseline and after the intervention.
The mean (standard deviation, SD) age was 11.07 (2.00) years and 11.23 (2.37) years for the placebo and synbiotic groups, respectively (P = 0.770). The waist-height ratio (WHtR) decreased significantly at the end of the intervention in comparison with baseline in the synbiotic group (0.54 ± 0.05 vs. 0.55 ± 0.05, P = 0.05). No significant changes were demonstrated in other anthropometric indices or body composition between groups.
Synbiotic supplementation might be associated with a reduction in WHtR. There were no significant changes in other anthropometric indices or body composition.
最近,益生菌和/或益生元对成年人心血管代谢危险因素的有益影响已得到证实。然而,针对儿科年龄组的证据尚未完全确立。本研究旨在评估合生元对超重或肥胖儿童和青少年体重指数和身体成分的影响。
这是一项随机、双盲、安慰剂对照试验,纳入了 60 名年龄在 8-18 岁、体重指数(BMI)等于或高于第 85 百分位的参与者。参与者被随机分为两组,分别服用含有 6×10 菌落形成单位(CFU)凝结芽孢杆菌 SC-208、6×10 CFU 印度乳杆菌 HU36 和低聚果糖的合生元胶囊(n=30)或安慰剂(n=30),每天两次,持续八周。在基线和干预后测量体重指数和身体成分。
安慰剂组和合生元组的平均(标准差,SD)年龄分别为 11.07(2.00)岁和 11.23(2.37)岁(P=0.770)。与基线相比,干预结束时合生元组的腰围身高比(WHtR)显著降低(0.54±0.05 比 0.55±0.05,P=0.05)。两组间其他体重指数或身体成分均无显著变化。
合生元补充剂可能与 WHtR 的降低有关。其他体重指数或身体成分无显著变化。